The ability of all-trans-retinoic acid to stimulate granulocytic differentiation makes it useful in the treatment of acute promyelocytic leukemia. Recent findings suggest that this drug can also induce post-maturation apoptosis through the Apo-2L/TRAIL death ligand (pages 680–686).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Altucci, L. et al. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nature Med. 7, 680–686 (2001).
Lin, R.J., Egan, D.A. & Evans, R.M. Molecular genetics of acute promyelocytic leukemia. Trends Genet. 15, 179–184 (1999).
Guidez, F. & Zelent, A. Nuclear receptor corepressors in leukaemogenesis. Curr. Top. Microbiol. Immunol. 254, 165–185 (2000).
Fenaux, P., Chomienne, C. & Degos, L. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin. Hematol. 38, 13–25 (2001).
Walczak, H. et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nature Med. 5, 157–163 (1999).
Sprick, M.R. et al. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12, 599–609 (2000).
Bodmer, J.L. et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nature Cell Biol. 2, 241–243 (2000).
Ashkenazi, A. & Dixit, V.M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11, 255–260 (1999).
Degli-Esposti, M.A. et al. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7, 813–820 (1997).
Chaudhary, P.M. et al. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway. Immunity 7, 821–830 (1997).
Akgul, C., Moulding, D.A. & Edwards, S.W. Molecular control of neutrophil apoptosis. FEBS Lett. 487, 318–322 (2001).
Zamai, L. et al. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood 95, 3716–3724 (2000).
Kitamura, K. et al. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia 14, 1743–1750 (2000).
Benoit, G. et al. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. EMBO J. 18, 7011–7018 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zelent, A. Hot on the TRAIL of acute promyelocytic leukemia. Nat Med 7, 662–664 (2001). https://doi.org/10.1038/89031
Issue Date:
DOI: https://doi.org/10.1038/89031
This article is cited by
-
Translocations of the RARα gene in acute promyelocytic leukemia
Oncogene (2001)
-
The promise of retinoids to fight against cancer
Nature Reviews Cancer (2001)